These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2323818)

  • 21. Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.
    Rappuoli R; Pizza M; Covacci A; Bartoloni A; Nencioni L; Podda A; De Magistris MT
    FEMS Microbiol Immunol; 1992 Oct; 5(4):161-70. PubMed ID: 1384602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.
    Peppoloni S; Pizza M; De Magistris MT; Bartoloni A; Rappuoli R
    Physiol Chem Phys Med NMR; 1995; 27(4):355-61. PubMed ID: 8768791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.
    Marsili I; Pizza M; Giovannoni F; Volpini G; Bartalini M; Olivieri R; Rappuoli R; Nencioni L
    Infect Immun; 1992 Mar; 60(3):1150-5. PubMed ID: 1541530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene replacement in Bordetella pertussis by transformation with linear DNA.
    Zealey GR; Loosmore SM; Yacoob RK; Cockle SA; Boux LJ; Miller LD; Klein MH
    Biotechnology (N Y); 1990 Nov; 8(11):1025-9. PubMed ID: 1366929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
    Chong P; Cockle S; Boux H; Klein M
    Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis.
    Olander RM; Muotiala A; Himanen JP; Karvonen M; Airaksinen U; Runeberg-Nyman K
    Microb Pathog; 1991 Feb; 10(2):159-64. PubMed ID: 1909767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
    Loosmore SM; Zealey GR; Boux HA; Cockle SA; Radika K; Fahim RE; Zobrist GJ; Yacoob RK; Chong PC; Yao FL
    Infect Immun; 1990 Nov; 58(11):3653-62. PubMed ID: 2228237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.
    Simondon F; Yam A; Gagnepain JY; Wassilak S; Danve B; Cadoz M
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):927-32. PubMed ID: 9031875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge.
    Nascimento IP; Dias WO; Quintilio W; Christ AP; Moraes JF; Vancetto MD; Ribeiro-Dos-Santos G; Raw I; Leite LC
    Microbes Infect; 2008 Feb; 10(2):198-202. PubMed ID: 18248757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cellular and acellular anti-pertussis vaccines].
    Locht C
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of antibodies elicited by immunization with pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Gotto J
    Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The concept of pertussis as a toxin-mediated disease.
    Pittman M
    Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.
    Xing DK; Canthaboo C; Corbel MJ
    Vaccine; 2000 Apr; 18(20):2110-9. PubMed ID: 10715525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H; Ito A; Chiba J; Sato Y
    Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine.
    Boursaux-Eude C; Thiberge S; Carletti G; Guiso N
    Vaccine; 1999 Jun; 17(20-21):2651-60. PubMed ID: 10418915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.